Observations: How the FDA forgot the evidence: The case of donepezil ( Aricept) 23 mg Approval for a new dose of a best-selling Alzheimer’s drug “breached the FDA’s own regulatory standard” and has led to “incomplete and distorted messages” about the… Read More ›